Renmatix Unveils Biomass Technology

More Business Concentrates

• BASF Fertilizer Business Going To Russia’s EuroChem
• BASF has agreed to sell most of its fertilizer business to Moscow-based EuroChem for about $950 million...
• Evonik Pulls Back IPO, Invests In R&D
• Evonik Industries has once again shelved an initial public offering (IPO) of stock. In April, RAG Foundation, which owns about 75% of the firm...
• Ticona Starts Up Polymer Plant
• Celanese’s Ticona unit has started up a new polyoxymethylene (POM) plant at the Frankfurt Hoechst Industrial Park in Germany...
• DuPont Plans China Fluoropolymer Venture With 3F
• DuPont and Shanghai 3F New Materials have signed a letter of intent for a 50-50 joint venture that will make fluoropolymers in Changshu...
• Amyris And Michelin To Pursue Isoprene
• Amyris has signed an agreement to collaborate with tire maker Michelin on the development of isoprene from plant-based sugars...
• Fulcrum Bioenergy Readies Stock Offer
• Garbage-to-ethanol start-up Fulcrum BioEnergy has filed for an initial public offering of stock worth up to $115 million...
• Renmatix Unveils Biomass Technology
• Renmatix has unveiled details of its Plant­rose supercritical hydrolysis process for making industrial sugars from plant biomass...
• China Tightens Rare-Earth Controls
• China’s Ministry of Land & Resources plans to increase its oversight of rare-earth metals production...
• California Gets Lithium Carbonate
• Simbol Materials has begun operations at a 500-metric-ton-per-year high-purity lithium carbonate facility near the Salton Sea in California...
• Kureha Debuts Polyglycolic Acid
• Japan’s Kureha has opened the world’s first commercial-scale polyglycolic acid (PGA) facility at DuPont’s site in Belle, W.Va...
• Rusnano Invests In Cleveland BioLabs
• Cleveland BioLabs will launch an oncology-focused subsidiary called Panacela Labs with support from the Russian Corporation of Nanotechnologies...
• Enzon, NeuroSearch To Slash Jobs
• Enzon Pharmaceuticals is slashing its workforce almost in half and cutting its operating costs to better align resources with its R&D activities...
• BMS, Ambrx Partner On Biotherapies
• Bristol-Myers Squibb is acquiring worldwide rights to research, develop, and commercialize biologics based on Ambrx’ Fibroblast Growth Factor 21 (FGF-21)...
• Business Roundup
• LyondellBasell, PPG Industries, Siluria, Zeachem, Colombiana, Lanxess, Monsanto, Teva Pharmaceutical Industries, RXi Pharmaceuticals ...

Topics Covered

biobased chemicals, sugar, supercritical water